ResearcherGerman Cancer Research CenterNo recent work listed

Sarah Schott

ORCID-verified (high confidence)As of 10 November 2026

Matched on ORCID iD 0000-0002-1714-1147; OpenAlex author ID A5018260367.

Their work

Papers: 1 (first author 1, last author 0)
Trials: 0
Grants: 0
Collaborators: 5

Papers, trials and grants by year

2017: 1 paper

Papers 1

HYAL2 methylation in peripheral blood as a potential marker for the detection of pancreatic cancer: a case control study. First author DOI 10.18632/oncotarget.18757 ↗

Closest collaborators

The 5 strongest of 5 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Nathalia A. Giese · 1 shared paper, 2017
- Paper HYAL2 methylation in peripheral blood as a potential marker for the detection of pancreatic cancer: a case control stud… DOI 10.18632/oncotarget.18757 ↗
Federico Canzian · 1 shared paper, 2017
- Paper HYAL2 methylation in peripheral blood as a potential marker for the detection of pancreatic cancer: a case control stud… DOI 10.18632/oncotarget.18757 ↗
Thilo Hackert · 1 shared paper, 2017
- Paper HYAL2 methylation in peripheral blood as a potential marker for the detection of pancreatic cancer: a case control stud… DOI 10.18632/oncotarget.18757 ↗
Oliver Strobel · 1 shared paper, 2017
- Paper HYAL2 methylation in peripheral blood as a potential marker for the detection of pancreatic cancer: a case control stud… DOI 10.18632/oncotarget.18757 ↗
Barbara Burwinkel · 1 shared paper, 2017
- Paper HYAL2 methylation in peripheral blood as a potential marker for the detection of pancreatic cancer: a case control stud… DOI 10.18632/oncotarget.18757 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.